We have located links that may give you full text access.
Partitioning of the alveolar-arterial O2 pressure difference under normal, hypoxic and hyperoxic conditions.
The alveolar-arterial O2 pressure difference (AaDO2) is composed of three parts which depend on inhomogeneities of the ventilation-perfusion ratio (AaD(distr.) 1), on size and distribution of the diffusing capacity-perfusion ratio (AaD(distr.) 2), and on the effect of the shunt perfusion (AaD(sh)). These three parts can be calculated for normal, hypoxic and hyperoxic breathing conditions if the inhomogeneities of the function parameters and the size of the shunt perfusion are known. The calculation based on experimental data in 28 healthy subjects shows the following results: (1) Under hypoxic breathing conditions the AaD(distr.) 2 due to diffusion dominates. However, even at alveolar O2 pressures below 45 mm Hg the AaD(distr.) 1 must not be ignored. (2) Under normal breathing conditions AaD(distr.) 2 may be ignored and will under pathological conditions become relevant only if the diffusing capacity-perfusion ratio is below 3.10(-3) mm Hg(-1). (3) Under hyperoxic breathing conditions the AaD(sh) is predominant. However, even with the inhalation of pure oxygen, the AaD(distr.) 1 contributes 10% of the total AaDO2. (4) When evaluating the methods of measurement of the O2 diffusing capacity and of the shunt perfusion the inhomogeneities of ventilation, perfusion and diffusion must be considered.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app